Deferred Tax Assets, Valuation Allowance of Salarius Pharmaceuticals, Inc. from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Salarius Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2014 to 31 Dec 2024.
  • Salarius Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $17,098,218, a 7.5% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Salarius Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $17,098,218 +$1,199,319 +7.5% 31 Dec 2024 10-K 21 Mar 2025 2024 FY
Q4 2023 $15,898,899 +$2,856,143 +22% 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q4 2022 $13,042,756 +$6,867,725 +111% 31 Dec 2022 10-K 22 Mar 2024 2023 FY
Q4 2021 $6,175,031 +$3,336,021 +118% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q4 2020 $2,839,010 +$1,886,129 +198% 31 Dec 2020 10-K 25 Mar 2022 2021 FY
Q4 2019 $952,881 -$32,834,029 -97% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q4 2018 $33,786,910 +$5,253,155 +18% 31 Dec 2018 10-K 06 Mar 2019 2018 FY
Q4 2017 $28,533,755 +$406,144 +1.4% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q4 2016 $28,127,611 +$15,439,210 +122% 31 Dec 2016 10-K 07 Mar 2018 2017 FY
Q4 2015 $12,688,401 +$9,937,106 +361% 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q4 2014 $2,751,295 31 Dec 2014 10-K 08 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.